Analysis Arrowhead Pharmaceuticals Embarks on Strategic Investor Outreach Following Key Drug Approval
Having secured its first U.S. market authorization for a flagship therapy, Arrowhead Pharmaceuticals is now initiating a concerted campaign to engage the investment community. The biotech firm is set to...